Morforex

Add links
Source: Wikipedia, the free encyclopedia.
Morforex
Clinical data
ATC code
  • None
Identifiers
  • 4-[2-[(α-Methylphenethyl)amino]ethyl]morpholine
JSmol)
  • CC(Cc1ccccc1)NCCN2CCOCC2
  • InChI=1S/C15H24N2O/c1-14(13-15-5-3-2-4-6-15)16-7-8-17-9-11-18-12-10-17/h2-6,14,16H,7-13H2,1H3
  • Key:ISEKMORYCCULAL-UHFFFAOYSA-N

Morforex (

INN; Bo 637), also referable to as N-morpholinoethylamphetamine, is an anorectic which was never marketed.[1][2]

It produces amphetamine as an active metabolite.[3]

Synthesis

Patent:[4]

Amphetamine is reacted with N-Chloroethylmorpholine [3240-94-6] in the presence of IPA solvent.

See also

References

  1. ISBN 978-0-412-46630-4
    .
  2. ISBN 978-0-11-986227-0
    .
  3. ISBN 978-0-203-64196-5
    .
  4. ^ FR 2199M, "N-morpholino-1 n-phénylisopropylamino-2 éthane [N-morpholino-1 N-phenylisopropylamino-2 ethane]", published 1963-12-09, assigned to Brevets Pharmaceutiques et Cosmetologiques 


drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Morforex&oldid=1187681988"